| Reporter | TradeFlow | ProductCode | Product Description | Year | Partner | Trade Value 1000USD | Quantity | Quantity Unit |
| United Kingdom | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | World | 9,026.19 | 35,259 | Kg |
| United Kingdom | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Netherlands | 4,087.91 | 2,254 | Kg |
| United Kingdom | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Spain | 1,060.65 | 1,792 | Kg |
| United Kingdom | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Switzerland | 948.20 | 415 | Kg |
| United Kingdom | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Belgium | 904.42 | 4,785 | Kg |
| United Kingdom | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Hong Kong, China | 842.93 | 1,664 | Kg |
| United Kingdom | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | United States | 773.36 | 71 | Kg |
| United Kingdom | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Ireland | 114.16 | 227 | Kg |
| United Kingdom | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Gibraltar | 108.68 | 294 | Kg |
| United Kingdom | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Brazil | 39.75 | 20,700 | Kg |
| United Kingdom | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Germany | 34.10 | 10 | Kg |
| United Kingdom | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Italy | 16.71 | 20 | Kg |
| United Kingdom | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Estonia | 14.02 | 33 | Kg |
| United Kingdom | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Australia | 13.62 | 16 | Kg |
| United Kingdom | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | France | 12.04 | 21 | Kg |
| United Kingdom | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | China | 7.14 | 9 | Kg |
| United Kingdom | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Ukraine | 6.28 | 22 | Kg |
| United Kingdom | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Bahamas, The | 6.21 | 42 | Kg |
| United Kingdom | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Austria | 5.50 | 133 | Kg |
| United Kingdom | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Norway | 5.49 | 935 | Kg |
| United Kingdom | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Iraq | 5.42 | 4 | Kg |
| United Kingdom | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Turkey | 4.68 | 51 | Kg |
| United Kingdom | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Cyprus | 3.56 | 4 | Kg |
| United Kingdom | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | India | 3.43 | 36 | Kg |
| United Kingdom | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Indonesia | 3.36 | 12 | Kg |
| United Kingdom | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Serbia, FR(Serbia/Montenegro) | 2.44 | 35 | Kg |
| United Kingdom | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Nigeria | 2.05 | 4 | Kg |
| United Kingdom | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Cameroon | 0.08 | 1,670 | Kg |
